References
Key articles
Stout KS, Daniels CJ, Aboulhosn JA, et al. 2018 AHA/ACC guideline for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019 Apr 2;139(14):e698-800.Full text Abstract
Baumgartner H, De Backer J, Babu-Narayan SV, et al. 2020 ESC guidelines for the management of adult congenital heart disease. Eur Heart J. 2021 Feb 11;42(6):563-645.Full text Abstract
Expert Panels on Cardiac Imaging and Pediatric Imaging; Krishnamurthy R, Suman G, Chan SS, et al. ACR appropriateness criteria® congenital or acquired heart disease. J Am Coll Radiol. 2023 Nov;20(11s):S351-81.Full text Abstract
John AS, Jackson JL, Moons P, et al. Advances in managing transition to adulthood for adolescents with congenital heart disease: a practical approach to transition program design: a scientific statement from the American Heart Association. J Am Heart Assoc. 2022 Apr 5;11(7):e025278.Full text Abstract
Reference articles
1. Warnes CA, Williams RG, Bashore TM, et al. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). Developed in collaboration with the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008 Dec 2;52(23):e143-263.Full text Abstract
2. Stout KS, Daniels CJ, Aboulhosn JA, et al. 2018 AHA/ACC guideline for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019 Apr 2;139(14):e698-800.Full text Abstract
3. Lopez L, Houyel L, Colan SD, et al. Classification of ventricular septal defects for the eleventh iteration of the International Classification of Diseases-Striving for Consensus: a report from the International Society for Nomenclature of Paediatric and Congenital Heart Disease. Ann Thorac Surg. 2018 Nov;106(5):1578-89. Abstract
4. World Health Organization. International classification of diseases 11th revision (ICD-11). Jan 2022 [internet publication].Full text
5. Arvanitaki A, Giannakoulas G, Baumgartner H, et al. Eisenmenger syndrome: diagnosis, prognosis and clinical management. Heart. 2020 Nov;106(21):1638-45. Abstract
6. Birnbaum Y, Fishbein MC, Blanche C, et al. Ventricular septal defect after acute myocardial infarction. New Engl J Med. 2002 Oct 31;347(18):1426-32. Abstract
7. Liu Y, Chen S, Zühlke L, et al. Global birth prevalence of congenital heart defects 1970-2017: updated systematic review and meta-analysis of 260 studies. Int J Epidemiol. 2019 Apr 1;48(2):455-63.Full text Abstract
8. Garne E. Atrial and ventricular septal defects - epidemiology and spontaneous closure. J Matern Fetal Neonatal Med. 2006 May;19(5):271-6. Abstract
9. Li X, Song GX, Wu LJ, et al. Prediction of spontaneous closure of isolated ventricular septal defects in utero and postnatal life. BMC Pediatr. 2016 Dec 8;16(1):207.Full text Abstract
10. Li X, Ren W, Song G, et al. Prediction of spontaneous closure of ventricular septal defect and guidance for clinical follow-up. Clin Cardiol. 2019 May;42(5):536-41.Full text Abstract
11. Baumgartner H, De Backer J, Babu-Narayan SV, et al. 2020 ESC guidelines for the management of adult congenital heart disease. Eur Heart J. 2021 Feb 11;42(6):563-645.Full text Abstract
12. Centers for Disease Control and Prevention. Congenital heart defects (CHDs): about ventricular septal defect. May 2024 [internet publication].Full text
13. Reller MD, Strickland MJ, Riehle-Colarusso, et al. Prevalence of congenital heart defects in metropolitan Atlanta, 1998-2005. J Paediatr. 2008 Dec;153(6):807-13. Abstract
14. Freeman SB, Taft LF, Dooley KJ, et al. Population-based study of congenital heart defects in Down syndrome. Am J Med Genet. 1998 Nov 16;80(3):213-7. Abstract
15. Freeman SB, Bean LH, Allen EG, et al. Ethnicity, sex, and the incidence of congenital heart defects: a report from the National Down Syndrome Project. Genet Med. 2008 Mar;10(3):173-80.Full text Abstract
16. Tubman RJ, Shields MD, Craig BG, et al. Congenital heart disease in Down's syndrome: two year prospective early screening study. BMJ. 1991 Jun 15;302(6790):1425-7. Abstract
17. Martin SS, Aday AW, Almarzooq ZI, et al. 2024 Heart disease and stroke statistics: a report of US and global data from the American Heart Association. Circulation. 2024 Feb 20;149(8):e347-913.Full text Abstract
18. Øyen N, Poulsen G, Boyd HA, et al. Recurrence of congenital heart defects in families. Circulation. 2009 Jul 28;120(4):295-301.Full text Abstract
19. Mateja WA, Nelson DB, Kroelinger CD, et al. The association between maternal alcohol use and smoking in early pregnancy and congenital cardiac defects. J Womens Health (Larchmt). 2012 Jan;21(1):26-34. Abstract
20. Bolin EH, Gokun Y, Romitti PA, et al. Maternal smoking and congenital heart defects, National Birth Defects Prevention Study, 1997-2011. J Pediatr. 2022 Jan;240:79-86.Full text Abstract
21. Expert Panels on Cardiac Imaging and Pediatric Imaging; Krishnamurthy R, Suman G, Chan SS, et al. ACR appropriateness criteria® congenital or acquired heart disease. J Am Coll Radiol. 2023 Nov;20(11s):S351-81.Full text Abstract
22. Corbett L, Forster J, Gamlin W, et al. A practical guideline for performing a comprehensive transthoracic echocardiogram in the congenital heart disease patient: consensus recommendations from the British Society of Echocardiography. Echo Res Pract. 2022 Oct 18;9(1):10.Full text Abstract
23. Writing Group, Sachdeva R, Valente AM, et al. ACC/AHA/ASE/HRS/ISACHD/SCAI/SCCT/SCMR/SOPE 2020 appropriate use criteria for multimodality imaging during the follow-up care of patients with congenital heart disease: a report of the American College of Cardiology solution set oversight committee and appropriate use criteria task force, American Heart Association, American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Pediatric Echocardiography. J Am Soc Echocardiogr. 2020 Oct;33(10):e1-48. Abstract
24. Jone PN, Ivy DD, Hauck A, et al. Pulmonary hypertension in congenital heart disease: a scientific statement from the American Heart Association. Circ Heart Fail. 2023 Jul;16(7):e00080.Full text Abstract
25. Wasserman MA, Shea E, Cassidy C, et al. Recommendations for the adult cardiac sonographer performing echocardiography to screen for critical congenital heart disease in the newborn: from the American Society of Echocardiography. J Am Soc Echocardiogr. 2021 Mar;34(3):207-22.Full text Abstract
26. John AS, Jackson JL, Moons P, et al. Advances in managing transition to adulthood for adolescents with congenital heart disease: a practical approach to transition program design: a scientific statement from the American Heart Association. J Am Heart Assoc. 2022 Apr 5;11(7):e025278.Full text Abstract
27. Sood E, Newburger JW, Anixt JS, et al. Neurodevelopmental outcomes for individuals with congenital heart disease: updates in neuroprotection, risk-stratification, evaluation, and management: a scientific statement from the American Heart Association. Circulation. 2024 Mar 26;149(13):e997-1022.Full text Abstract
28. Yang J, Yang L, Yu S, et al. Transcatheter versus surgical closure of perimembranous ventricular septal defects in children: a randomized controlled trial. J Am Coll Cardiol. 2014 Apr 1;63(12):1159-68.Full text Abstract
29. Szkutnik M, Qureshi SA, Kusa J, et al. Use of the Amplatzer muscular ventricular septal defect occluder for closure of perimembranous ventricular septal defects. Heart. 2007 Mar;93(3):355-8. Abstract
30. Masura J, Gao W, Gavora P, et al. Percutaneous closure of perimembranous ventricular septal defects with the eccentric Amplatzer device: multicenter follow-up study. Pediatr Cardiol. 2005 May-Jun;26(3):216-9. Abstract
31. Fu YC, Bass J, Amin Z, et al. Transcatheter closure of perimembranous ventricular septal defects using the new Amplatzer membranous VSD occluder: results of the U.S. phase I trial. J Am Coll Cardiol. 2006 Jan 17;47(2):319-25. Abstract
32. Butera G, Carminati M, Chessa M, et al. Transcatheter closure of perimembranous ventricular septal defects: early and long-term results. J Am Coll Cardiol. 2007 Sep 18;50(12):1189-95. Abstract
33. Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA Guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022 May 3;145(18):e895-e1032.Full text Abstract
34. Chau EM, Fan KY, Chow WH. Effects of chronic sildenafil in patients with Eisenmenger syndrome versus idiopathic pulmonary arterial hypertension. Int J Cardiol. 2007 Sep 3;120(3):301-5. Abstract
35. Barst RJ, Ivy DD, Gaitan G, et al. A randomized, double-blind, placebo-controlled, dose-ranging study of oral sildenafil citrate in treatment-naive children with pulmonary arterial hypertension. Circulation. 2012 Jan 17;125(2):324-34. Abstract
36. Galiè N, Beghetti M, Gatzoulis MA, et al. Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study. Circulation. 2006 Jul 4;114(1):48-54. Abstract
37. Fernandes SM, Newburger JW, Lang P, et al. Usefulness of epoprostenol therapy in the severely ill adolescent/adult with Eisenmenger physiology. Am J Cardiol. 2003 Mar 1;91(5):632-5. Abstract
38. Luna-Lopez R, Segura de la Cal T, Sarnago Cebada F, et al. Triple vasodilator therapy in pulmonary arterial hypertension associated with congenital heart disease. Heart. 2024 Feb 12;110(5):346-52. Abstract
39. Ferrero P, Krishnathasan K, Constantine A, et al. Pulmonary arterial hypertension in congenital heart disease. Heart. 2023 Nov 14:heartjnl-2023-322890.
40. Perrotta S, Lentini S. In patients undergoing surgical repair of post-infarction ventricular septal defect, does concomitant revascularization improve prognosis? Interact Cardiovasc Thorac Surg. 2009 Nov;9(5):879-87.Full text Abstract
41. Landzberg MJ, Lock JE. Transcatheter management of ventricular septal rupture after myocardial infarction. Semin Thorac Cardiovasc Surg. 1998 Apr;10(2):128-32. Abstract
42. Pesonen E, Thilen U, Sandstrom S, et al. Transcatheter closure of post-infarction ventricular septal defect with the Amplatzer Septal Occluder device. Scand Cardiovasc J. 2000 Aug;34(4):446-8. Abstract
43. Gabriel HM, Heger M, Innerhofer P, et al. Long-term outcome of patients with ventricular septal defect considered not to require surgical closure during childhood. J Am Coll Cardiol. 2002 Mar 20;39(6):1066-71. Abstract
44. Christie JD, Edwards LB, Kucheryavaya AY, et al. The registry of the International Society for Heart and Lung Transplantation: 29th adult lung and heart-lung transplant report-2012. J Heart Lung Transplant. 2012 Oct;31(10):1073-86.Full text
45. Pienvichit P, Piemonte TC. Percutaneous closure of postmyocardial infarction ventricular septal defect with the CardioSEAL septal occluder implant. Catheter Cardiovasc Interv. 2001 Dec;54(4):490-4. Abstract
46. Bukhari SM, Desai M, Zurakowski D, et al. Fate of aortic regurgitation after isolated repair of ventricular septal defect with concomitant aortic regurgitation in children. JTCVS Open. 2023 Mar;13:271-7.Full text Abstract
47. Liberman L, Silver ES, Chai PJ, et al. Incidence and characteristics of heart block after heart surgery in pediatric patients: a multicenter study. J Thorac Cardiovasc Surg. 2016 Jul;152(1):197-202.Full text Abstract
Use of this content is subject to our disclaimer